Stockreport

Cerecor Receives Fast Track Designation from FDA for CERC-802 for the Treatment of Mannose-Phosphate Isomerase Deficiency

Cerecor, Inc  (CERC) 
Last cerecor, inc earnings: 11/14 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: ir.cerecor.com
PDF ROCKVILLE, Md., Aug. 21, 2019 (GLOBE NEWSWIRE) -- Cerecor Inc. (NASDAQ: CERC), a biopharmaceutical company focused on becoming a leader in development and commercializ [Read more]